Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
posaconazole
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
gptkb:J02AC13
|
| gptkbp:brand |
posaconazole
|
| gptkbp:contraindication |
hypersensitivity to posaconazole
|
| gptkbp:drugClass |
triazole antifungal
|
| gptkbp:form |
intravenous solution
oral suspension delayed-release tablet |
| https://www.w3.org/2000/01/rdf-schema#label |
Noxafil
|
| gptkbp:indication |
prophylaxis of Aspergillus infections
prophylaxis of Candida infections |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
fever
nausea vomiting diarrhea headache |
| gptkbp:usedFor |
prevention of invasive fungal infections
treatment of oropharyngeal candidiasis |
| gptkbp:bfsParent |
gptkb:Merck_&_Co.
|
| gptkbp:bfsLayer |
4
|